Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 12, 2011, Pages 2809-2813

  Idelevich, Evgeny A ^a   Kriegeskorte, André ^a   Stubbings, William ^b,d   Kahl, Barbara C ^a   Peters, Georg ^a,c   Becker, Karsten ^a,c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b MerLion Pharmaceuticals GmbH   (Germany)

^c Interdisciplinary Center for Clinical Research IZKF Münster   (Germany)

^d BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

Author keywords

Acidic conditions; Fluoroquinolones; Staphylococcus aureus; Susceptibility testing

Indexed keywords

CIPROFLOXACIN; FINAFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM COLONY; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; EPSILOMETER TEST; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PH; PHENOTYPE; STAPHYLOCOCCUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS LUGDUNENSIS; WILD TYPE;

ANTI-BACTERIAL AGENTS; CULTURE MEDIA; FLUOROQUINOLONES; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; MUTATION; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 81855199766     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr393     Document Type: Article

References (32)

1. Sachse F, Becker K, von Eiff C et al. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy 2010; 65: 1430-7.
2. Tuchscherr L, Heitmann V, Hussain M et al. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis 2010; 202: 1031-40.
3. von Eiff C, Peters G, Becker K. The small colony variant (SCV) concept- the role of staphylococcal SCVs in persistent infections. Injury 2006; 37 Suppl 2: S26-33.
4. Proctor RA, von Eiff C, Kahl BC et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006; 4: 295-305.
5. von Eiff C, Becker K. Small-colony variants (SCVs) of staphylococci: a role in foreign body-associated infections. Int J Artif Organs 2007; 30: 778-85.
6. Kahl B, Herrmann M, Everding AS et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998; 177: 1023-9.
7. Kahl BC, Duebbers A, Lubritz G et al. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J Clin Microbiol 2003; 41: 4424-7.
8. Higgins PG, Stubbings W, Wisplinghoff H et al. Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacinsensitive and -resistant Acinetobacter baumannii isolates. Antimicrob Agents Chemother 2010; 54: 1613-5.
9. Tate S, MacGregor G, Davis M et al. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 2002; 57: 926-9.
10. Weinrick B, Dunman PM, McAleese F et al. Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol 2004; 186: 8407-23.
11. Sendi P, Rohrbach M, Graber P et al. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 2006; 43: 961-7.
12. von Eiff C, Bettin D, Proctor RA et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 1997; 25: 1250-1.
13. von Eiff C, Becker K, Metze D et al. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier's disease. Clin Infect Dis 2001; 32: 1643-7.
14. Kipp F, Ziebuhr W, Becker K et al. Detection of Staphylococcus aureus by 16S rRNA directed in situ hybridisation in a patient with a brain abscess caused by small colony variants. J Neurol Neurosurg Psychiatry 2003; 74: 1000-2.
15. Lannergård J, von Eiff C, Sander G et al. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52: 4017-22.
16. von Eiff C, Lubritz G, Heese C et al. Effect of trimethoprimsulfamethoxazole prophylaxis in AIDS patients on the formation of the small colony variant phenotype of Staphylococcus aureus. Diagn Microbiol Infect Dis 2004; 48: 191-4.
17. Seifert H, Oltmanns D, Becker K et al. Staphylococcus lugdunensis pacemaker-related infection. Emerg Infect Dis 2005; 11: 1283-6.
18. Goering RV, Winters MA. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol 1992; 30: 577-80.
19. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
20. Harmsen D, Claus H, Witte W et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41: 5442-8.
21. Hussain M, von Eiff C, Sinha B et al. eap gene as a novel target for specific identification of Staphylococcus aureus. J Clin Microbiol 2008; 46: 470-6.
22. Becker K, Al Laham N, Fegeler W et al. Fourier-transform infrared spectroscopic analysis is a powerful tool for studying the dynamic changes in Staphylococcus aureus small-colony variants. J Clin Microbiol 2006; 44: 3274-8.
23. von Eiff C, Heilmann C, Proctor RA et al. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 1997; 179: 4706-12.
24. Kipp F, Becker K, Peters G et al. Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus. J Clin Microbiol 2004; 42: 1277-9.
25. Etest for MIC determination. Etest product package inserts, bioMérieux SA, Marcy-l'Étoile, France. http://www.abbiodisk.com/bd_litt_prodPackIns.html (5 April 2011, date last accessed).
26. Proctor RA, Kahl B, von Eiff C et al. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis 1998; 27 Suppl 1: S68-74.
27. Besier S, Zander J, Siegel E et al. Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. J Clin Microbiol 2008; 46: 3829-32.
28. Chatterjee I, Kriegeskorte A, Fischer A et al. In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus. J Bacteriol 2008; 190: 834-42.
29. Besier S, Ludwig A, Ohlsen K et al. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int J Med Microbiol 2007; 297: 217-25.
30. Baumert N, von Eiff C, Schaaff F et al. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist 2002; 8: 253-60.
31. von Eiff C, Friedrich AW, Becker K et al. Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes. Antimicrob Agents Chemother 2005; 49: 4372-4.
32. von Eiff C, Schepers S, Peters G. Comparative in vitro activity of faropenem against staphylococci. J Antimicrob Chemother 2002; 50: 277-80.